Axxam is an innovative Partner Research Organization (iPRO) and a leading provider of integrated discovery services across life sciences industries, including pharmaceuticals, crop protection, animal health, cosmetics, fragrances, food and beverages. We have consolidated expertise in performing cell-based and biochemical assay development, high-throughput screening of both the Axxam high quality compound collections (small molecule compound libraries and natural product library) or those provided by our clients, compound management, hit identification and hit validation. Our innovative technologies include electrophysiology, high content screening, genome editing, optogenetics and iPSCs, among others. Axxam’s business terms are flexible, ranging from fee-for-service to FTE-based services.
Our performance-driven approach has been recognized by our clients as key to the success for their early-stage drug discovery programs.

The Health & Wellbeing Clust-ER of Emilia-Romagna is one of the key players in the regional innovation ecosystem: an association of public and private bodies as companies, research centers, hospitals and training institutions that share skills, ideas and resources to support the competitiveness of the sector, acting as an accelerator of innovation for the key strategic sectors and a multiplier of opportunities working through a collaborative approach. Nutraceutics, animal health, biomedical technologies, pharma and advanced therapies, big data and digital health, orthopedics, neuroscience and neurology are the seven assets on which Clust-ER health has built its own internationalization strategy, to attract investments and promote networking for business and research.

We are a partner research organization with decades of experience in translating nascent research into drug discovery programs, providing support across the drug discovery pipeline, and offering stand-alone services. With four therapeutics currently on the market, and over 25 candidates in clinical trials, our high-level R&D expertise is brought to every project through our seasoned leadership team, which oversees all programs. We can accelerate your preclinical drug discovery with our expertise in small molecules, peptides and antibody therapeutics. Our fully integrated solutions and expertise provide you with an enhanced understanding of both the biology and chemistry for your chosen therapeutic. All R&D is carried out under one roof in our state-of-the-art facilities, enabling us to provide seamless transitions between disciplines and faster turn-around times. All projects are matched with a team of highly adaptable scientists and a dedicated project representative to create tailor-made solutions, customized to your evolving needs.

The technology transfer office (TTO) helps researchers in managing their intellectual assets in ways that facilitate their transformation into benefits for society. In doing this, TTO helps to bridge the gap between research and innovation. This general role may be declined into more specific ones including: establish relationships with firms and community actors; generate new funding support from sponsored research or consulting opportunities; provide assistance on all areas related to entrepreneurship and intellectual property (IP); facilitate the formation of companies utilising Institution’s technology (start-up) and/or researcher’s (spin-off) to enhance prospects of further development; and TTO is responsible for preparing, drafting and updating intellectual property policies and procedures, encouraging technology development, assisting researchers in transferring technology to industry and others for the public benefit and supporting Spin-off and Start-up.

MATER-BI® is a range of bio-based plastics produced by NOVAMONT which are biodegradable and compostable.MATER-BI is used in many sectors (retail bags, packaging, fast food, waste sorting and agriculture) by providing unique and innovative solutions.

Olon Group is a global leader in the development and production of active pharmaceutical ingredients (APIs) for CDMO and generic markets, integrating chemical synthesis and biological processes while always embracing the highest international safety, quality, and environmental standards   With one of the longest track records of the API industry, having deep development expertise and a broad set of advanced technologies, we are the partner of choice which enables our client's molecules to enter the market successfully Olon has a global network of 11 manufacturing sites and 7 R&D centers across the globe. Thanks to our 2,300 employees, including 300 highly experienced and qualified R&D experts, we represent a highly innovative and reliable partner At Olon, expertise and competent flexibility throughout the organization help build successful outcomes for our clients in custom chemical synthesis and microbial fermentation, while always maintaining the highest levels of safety, quality, and environmental compliance

RISE Technology S.r.l. is a company that believes in the power of technology to enable progress in all fields and to minimize our negative impact on the environment, social and economic to make a more sustainable world. Founded in 2006, the company is an innovative and high-tech SME characterized by the ownership of technologies entirely conceived, designed and internally developed. The company, with headquarter in Rome, 1300 sqm production unit in San Martino di Lupari (Padova) and R&D facility at ENEL Innovation Hub&Lab in Passo Martino (Catania), has its core business in the design and manufacturing of photovoltaic, semiconductor and biomedical devices and equipments with its own know-how and production facilities. Innovation, sustainable development, and Industry 4.0 for advanced production systems combined with specialized and advanced skills in the photovoltaic, semiconductors, micro and nano technologies, biomedical and materials technologies are the strengths of the company.

Sacco System is an Italian owned multinational company that is a biotech hub for the food, nutraceutical, and pharmaceutical industries. A family-owned company active since 1872, Sacco System has grown organically and through strategic M&As to reach its current form. Sacco System continue to focus on bacterial manufacturing, research and development for nutraceutical and pharmaceutical fields. Our expertise helps solving consumer needs in more than 110 countries around the world, leveraging on our unique proprietary strains and customised blends. Our know-how is not limited to the lab, but with our two cGMP certified facilities we can support companies through development, process validation, and commercial production of probiotics, postbiotics, Next-Generation bacteria (obligate aerobic and anaerobic strains) and live biotherapeutics (LBPs). We continue to invest in Italy and abroad to ensure that we can offer cutting edge technologies to ensure our customers’ success.

Sapienza University of Rome, founded in 1303 by Pope Boniface VIII, is one of the oldest universities in the world, and a top performer in international university rankings. In occasion of Bio Japan 2023, Sapienza presents some innovative projects which are part of the Italian National Recovery and Resilience Plan:
 
D3 4HEALTH
Advanced digital technologies, with a sophisticated data mining process, for diagnosis, monitoring and treatment of human diseases.
 
ROME TECHNOPOLE
An Innovation Ecosystem made up of researchers and enterprises for the research, training and innovation in the health and biopharmaceuticals, energy transition, digital transition areas.
 
ONFOODS
Enabling technologies for sustainable development of agri-food production.
 
NATIONAL CENTER FOR GENE THERAPY AND DRUGS BASED ON RNA TECHNOLOGY
Focused in five major areas of human diseases.
 
HEAL ITALIA
Advanced Lab-research and Integrated Approaches of Precision Medicine for Innovative Therapies
 
INF-ACT
One Health Basic and Translational Research Actions addressing Unmet Needs on Emerging Infectious Diseases.

Eywa srl is a medical device manufacturer that produces and sells innovative products for regenerative medicine. Our core business is an electro-medical device called Limfa Therapy that accelerates the repair of bone and soft tissue damaged by trauma or chronic pathologies (osteoporosis, delayed consolidation, arthrosis, etc.) and is able to stimulate the differentiation of stem cells into type 2 collagen in a stylistically relevant manner. The extracorporeal stimulation occurs through the use of ultra- and super-weak, complex, variable and bipolar magnetic fields that have been patented by us and that form 29 stimulation sequences with the aim of selectively opening certain ion channels, causing the desired cellular reaction. The technology is fully automatic (programmes are preloaded in the device) and operator independent.

TheProphetAI is a technology startup bringing AI to the life science sector. Our AI-based services address the challenges that different players in this field may face. On one side, we assist suppliers and distributors of biological reagents in better understanding their customers' demands. As well as helping researchers during their work, we also provide a free AI-powered web application called www.GeneRecommender.com. At TheProphetAI we believe that a new era will be brought about by humans' unique skills combined with the capabilities of artificial intelligence. Using user-friendly applications powered by extremely advanced Machine Learning models, TheProphetAI enables its customers to take full advantage of artificial intelligence.

Sensosan is a Benefit Company to resolve a huge problem: improve the wellbeing of people on experience, health safety, mental health.
We do with Intelligent Nebulizers and with Fragrances for scent experience, sanitizing health safety and Functional for mental health.
Our innovative start-up was born in 2020 during the pandemic in Rome and at the Innovation Hub of Rovereto and it is composed of an entrepreneurial and research team with experience.
Our ESG vision is to improve SDGs: 3 Good Health & Wellbeing - 6 Clean Water & Sanification - 8 Decent Work & Economic Growth - 9 Industry, Innovation & Infrastructure - 11 Sustainable Cities & Communities - 15 Life On Land.
Our goal today is to help to return safety on indoor environments.